Aparna Ahuja - Jan 5, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Medical Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Jan 5, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2022, 12:01 PM
Next filing
Jan 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +154K +964.32% 170K Jan 5, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -154K -33.33% $0.00 307K Jan 5, 2022 Common Stock 154K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes 15,935 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on November 15, 2021.
F3 On January 5, 2021 the reporting person was granted 460,992 RSU's that vest in three equal annual installments beginning on January 5, 2021.